Effect of Ondansetron for Withdrawal Symptoms

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

We hope to determine whether Ondansetron, an anti-nausea medication, works to help relieve withdrawal symptoms experienced while the patient is being weaned off opioid medications. This medication has shown anecdotal evidence of being affective for the treatment of withdrawal symptoms and we hope to determine whether this is affective.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Treatments: Ondansetron

Criteria

Inclusion Criteria:-Over 18 years of age

• No medical contraindications to medication

• Able to fulfill research procedures Exclusion Criteria:-Subjects who are unable to respond to our questionnaires or to stimuli as required by the experimental protocol will be excluded.

• Subjects will be excluded if they have a history of significant psychiatric disorders that would prevent them from engaging in a treatment program.

• Participating in other studies that would interfere with the procedures in this study

• Known or apparent pregnancy